Showing results (371-380 of 417) with videos related to
Sort By:
Pageof 42
Hepatology (Baltimore, Md.)|August 3, 2013
Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control studyCristina Ripoll, Joan Genescà, Isis K Araujo, et al.Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011
Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineageRhys A Farrer, Lucy A Weinert, Jon Bielby, et al.Journal of Hepatology|October 25, 2025
Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.Journal of Hepatology|December 25, 2019
Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.Transplantation|July 21, 2022
Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical TrialDuilio Pagano, Jaime Bosch, Fabio Tuzzolino, et al.The Lancet Regional Health. Europe|June 10, 2026
Diagnostic innovation and models of care to improve fibrosis detection and risk stratification in steatotic liver diseaseNicola Pugliese, Trenton M White, Paul N Brennan, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019
Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.The American Journal of Gastroenterology|May 13, 2021
Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver DiseaseMonica Pons, Salvador Augustin, Bernhard Scheiner, et al.The Lancet. Gastroenterology & Hepatology|May 1, 2022
Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest GroupStuart McPherson, Matthew J Armstrong, Jeremy F Cobbold, et al.Nature Reviews. Endocrinology|February 22, 2023
Consensus Statement on the definition and classification of metabolic hyperferritinaemiaLuca Valenti, Elena Corradini, Leon A Adams, et al.Pageof 42